Noteworthy, efficacy of FHP01 in breast cancer cellular in vitro models was comparable to RK33 (Figure 2b) and was not strictly correlated to DDX3X expression (Figure 2c), as already shown for RK33 itself [23]. This evidence concerns the gene DDX3X and breast cancer.